Showing 6791-6800 of 7641 results for "".
- New Lipedema Fellowship Launcheshttps://practicaldermatology.com/news/new-lipedema-fellowship-launches/2458352/The Lipedema Society is launching an International Surgical Fellowship Program. Led by dermatologic surgeon David Amron, MD, medical director of the Roxbury Institute in Beverly Hills, Calif., the six-month fellowship will equip surgeons with the necessary knowledge, tools and methods req
- Novan: Significant Improvement of Genital Warts with SB206https://practicaldermatology.com/news/novan-significant-improvement-of-genital-warts-with-sb206/2458355/Top-line results from Novan Inc.’s Phase 2 clinical trial with SB206 for the treatment of genital warts caused by human papillomavirus, or HPV show statistically significant benefits, the company reports. The highest dose tested, SB206 12%, demonstrated a st
- ASDS Honors Awarded and New Board Members Electedhttps://practicaldermatology.com/news/asds-honors-and-new-board-members/2458362/Four members of the American Society for Dermatologic Surgery (ASDS) recently were recognized with the President’s Award for their extraordinary contributions to the Society or the specialty as a whole, and the ASDS awarded Jeanean D. Carruthers, MD, of Vancouver, British Columbia, Canada,
- Dermatology Scientist Sarah Millar Receives 2016 Focus Award For The Advancement Of Women In Medicinehttps://practicaldermatology.com/news/dermatology-scientist-sarah-millar-receives-2016-focus-award-for-the-advancement-of-women-in-medicine/2458364/Penn dermatology scientist Sarah E. Millar, PhD received the 2016 FOCUS Award for the Advancement of Women in Medicine. Millar, the Albert M. Kligman Endowed Professor and vice chair for basic science research in the department of Dermatology at the Perelman School of Medicine at the Univ
- Study: Anxiety, Depression May Travel with Hyperhidrosishttps://practicaldermatology.com/news/anxiety-depression-may-travel-with-hyperhidrosis/2458367/Individuals with hyperhidrosis are more likely to be anxious or depressed than their colleagues who don’t sweat excessively, new research suggests. Specifically, the prevalence of anxiety and depression was 21.3 percent and 27.2 percent in patients with hyperhidrosis, resp
- Merz On The Move: Reflections On Fiscal Year 2015/16https://practicaldermatology.com/news/merz-on-the-move-reflections-on-fiscal-year-201516/2458365/Merz Pharma’s core business has grown by 8.9 percent from EUR 809.8 million to EUR 881.9 million in fiscal 2015/16, the company reports. The company’s total revenue of EUR 1,092.9 million has declined by 5.5 percent compared to previous year
- Office Job, Stress And Diet May Increase Risk of Adult Acnehttps://practicaldermatology.com/news/office-job-stress-diet-may-increase-risk-of-adult-acne/2458370/Lifestyle factors -- including stress -- may play a role in adult acne development, a new study suggests. Researchers in Italy compared 248 women diagnosed with adult acne to 270 women without acne. They found that adult acne was associated with a personal history of acne in adolesce
- Novan: SB414 Inhibited IL-17 in Psoriasis Mouse Modelhttps://practicaldermatology.com/news/novan-sb414-inhibited-il-17-in-psoriasis-mouse-model/2458374/Novan, Inc. has announced preclinical data showing that its nitric oxide-releasing product candidate SB414 significantly (p<0.05) reduced composite psoriasis scores, which consist of erythema and plaque scores, and pro-inflammatory cytokines, including interleukin-17, or IL-17, in a
- Adriane M. Brown Joins Allergan's Board of Directorshttps://practicaldermatology.com/news/adriane-m-brown-joins-allergans-board-of-directors/2458375/Adriane M. Brown is joining Allergan’s board of directors effective February 2017. Ms. Brown is currently President and Chief Operating Officer of Intellectual Ventures LLC, a private global invention company focused on providing access to valua
- Two New Studies Suggest BPX-01 Topical Minocycline May Hold Advantageshttps://practicaldermatology.com/news/two-new-studies-suggest-bpx-01-topical-minocycline-may-hold-advantages/2458376/Taken together, two new studies suggest that BioPharmX Corp.’s BPX-01 topical minocycline may have a favorable pharmacokinetic advantage compared with oral minocycline for the treatment of acne vulgaris. The research was at the Skin Disease Edu